Last reviewed · How we verify
NCT04184193
Benefits of Pulmonary Rehabilitation in Patients With Severe Lymphangioleiomyomatosis (LAM)
trial testing Pulmonary Rehabilitation in Lymphangioleiomyomatosis in 58 participants. Completed in 23 December 2019.
23 December 2019
Quick facts
| Lead sponsor | Schön Klinik Berchtesgadener Land |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 58 |
| Start date | 3 December 2019 |
| Primary completion | 23 December 2019 |
| Estimated completion | 23 December 2019 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Pulmonary Rehabilitation
Conditions studied
- Lymphangioleiomyomatosis — all drugs for Lymphangioleiomyomatosis →
- LAM — all drugs for LAM →
- Pulmonary Rehabilitation — all drugs for Pulmonary Rehabilitation →
Sponsor
Schön Klinik Berchtesgadener Land
Who can join
18 and older, any sex, with Lymphangioleiomyomatosis or LAM. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Data from patients with the orphan disease of lymphangioleiomyomatosis (LAM) which performed a pulmonary Rehabilitation program will be analyzed retrospectively. Data will be taken from the internal data base of the reference Center (Schoen Klinik Berchtesgadener Land, Schoenau, Germany) where These data were collected during clinical routine. Data will be included from the year 2000 until now. A retrospectively matched COPD cohort will be included for comparison.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Benefits of pulmonary rehabilitation in patients with advanced lymphangioleiomyomatosis (LAM) compared with COPD - a retrospective analysis.
Gloeckl R, Nell C, Schneeberger T, Jarosch I, et al · · 2020 · cited 10× · PMID 32962746 · DOI 10.1186/s13023-020-01540-3
Verify or expand the search:
- PubMed search for NCT04184193
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Pulmonary Rehabilitation
Trials testing the same drug.
- NCT07197229 — Hospital- and Home-Based Structured Pulmonary Rehabilitation in Recently Admitted COPD Patients: A Quasi-Experimental St · NA · not yet recruiting
- NCT07376161 — Inflammation and Oxidative Stress in COPD · enrolling by invitation
- NCT07097961 — Paediatric Post-TB Pulmonary Rehab Study · NA · recruiting
- NCT06756230 — Downhill Walking in IPF · NA · recruiting
- NCT06707623 — CPET Guided Rehab vs Physiotherapy in Patients With Dysfunctional Breathing · NA · recruiting
Other recruiting trials for Lymphangioleiomyomatosis
Currently open trials in the same condition.
- NCT06160310 — Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry) · recruiting
- NCT05467397 — Feasibility of [11C]Acetate-PET in LAM and TSC · Phase 1, PHASE2 · active not recruiting
- NCT03150914 — Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial · Phase 3 · active not recruiting
- NCT01799538 — Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis · Phase 1, PHASE2 · recruiting
- NCT01552434 — Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced · Phase 1 · active not recruiting
Other Schön Klinik Berchtesgadener Land trials
Trials by the same sponsor.
- NCT07013903 — Effects of Hydrotherapy During Post-COVID-19 Rehabilitation · NA · recruiting
- NCT06545851 — Effects of an Automatic Oxygen Titration System in People With Hypoxemia During Exercise Training · NA · recruiting
- NCT05172206 — Symptom-based Rehabilitation Compared to Usual Care in Post-COVID - a Randomized Controlled Trial · NA · completed
- NCT05124548 — Sleep Characteristics in Post-COVID-19 Patients · completed
- NCT05126511 — Effects of Cranial Electrotherapy Stimulation on Anxiety of Patients After COVID-19 · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04184193 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Schön Klinik Berchtesgadener Land
- Last refreshed: 21 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04184193.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing